Utah's life sciences sector will converge at the 2025 Entrepreneur & Investor (E&I) Life Sciences Summit, hosted by BioUtah and the University of Utah's Technology Licensing Office. The March 13 event at the Sheraton Hotel in Salt Lake City promises to connect healthcare innovators with potential investors and provide critical insights into the evolving life sciences landscape.
Key speakers include Monica DiCenso from J.P. Morgan Private Bank, who will discuss the current investment environment, and Earl "Eb" Bright from Exploramed, who will explore entrepreneurial challenges and opportunities. The summit will feature top Utah life sciences CEOs and venture capital principals sharing strategies for early-stage company success.
A highlight of the event is the annual Pitch Competition, where life sciences companies will present innovations across categories including medical devices, pharmaceuticals, and digital health. Winners will receive cash prizes and recognition, potentially accelerating their path to commercialization.
The summit underscores Utah's emergence as a significant life sciences hub, with the industry contributing $22.6 billion to the state's GDP and supporting approximately 180,000 jobs. By facilitating connections between researchers, entrepreneurs, and investors, the event aims to transform groundbreaking discoveries into marketable technologies.
With more than 400 expected attendees, the E&I Summit represents a critical platform for networking, knowledge sharing, and potential investment opportunities in the rapidly evolving life sciences sector.
